- Home
- ->
- Industry News
May 12, 2020: Breast cancer patients are at a greater risk of adherence issues and treatment toxicities, which require closer monitoring and follow-ups
Outside link:
Adverse events (AEs) emphasize the need for pharmacists to conduct further monitoring, follow-ups and management of patients